## Analysis of Ectopic Pregnancy Management ### Why the Correct Answer (Option 1) is Wrong **Key Point:** Methotrexate can be safely used in ectopic pregnancy even with β-hCG levels above 10,000 mIU/mL, though success rates decline with higher levels. The absolute contraindication is NOT a β-hCG threshold of 10,000. - **β-hCG and methotrexate eligibility:** While success rates are higher when β-hCG < 5,000 mIU/mL, methotrexate is still used in carefully selected cases with β-hCG up to 50,000–100,000 mIU/mL, depending on institutional protocols and patient factors. - **This patient's situation:** With β-hCG of 15,000 and a 3 cm tubal mass with free fluid, medical management would be considered high-risk, but methotrexate is not absolutely contraindicated by the hCG level alone. - **True contraindications to methotrexate:** Active pulmonary disease, renal or hepatic dysfunction, immunodeficiency, blood dyscrasias, peptic ulcer disease, and hemodynamic instability. ### Validation of Other Options (All Correct) **Option 0 — Rupture risk and gestational sac diameter:** - Tubal rupture risk increases sharply when the gestational sac diameter exceeds 3.5–4 cm [cite:Cunningham Obstetrics 26e Ch 19]. - This patient's 3 cm mass is approaching this threshold, warranting urgent intervention. **Option 2 — Ampullary implantation:** - The ampulla (widest, most distensible segment) accounts for ~70% of tubal ectopic pregnancies [cite:Berek Gynecology 16e Ch 19]. - The isthmic portion (most common site of rupture due to narrow lumen) accounts for ~12%, and the fimbrial end ~11%. **Option 3 — Heterotopic pregnancy incidence:** - Heterotopic pregnancy occurs in ~1 in 30,000 spontaneous pregnancies, but the incidence rises to 1 in 100–200 after assisted reproductive technology [cite:ACOG Practice Bulletin #193]. - This is a clinically important consideration because an intrauterine pregnancy may mask the diagnosis of a concurrent ectopic. ## Clinical Pearl **High-Yield:** The decision to use methotrexate in ectopic pregnancy is multifactorial: β-hCG level, tubal mass size, hemodynamic stability, renal/hepatic function, and patient reliability for follow-up. A β-hCG of 15,000 alone does not contraindicate methotrexate; this patient would likely require surgical management due to the large mass size and free fluid, not the hCG level.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.